As a consequence, MMR protein status assessment is recommended by the National Comprehensive Cancer Network (NCCN) and the European Society of Medical Oncology (ESMO) guidelines for patients with resected stage II CRC, since adjuvant chemotherapy may be avoided in dMMR individuals [116,122]. Here, MRC1 is linked to colorectal carcinoma.